CorMedix Will Be Part of Panel at Biotech Conference

CorMedix (NYSE:CRMD) announced its chief scientific officer Dr. Antony Pfaffle will present at an upcoming biotech conference.
As quoted in the press release:

Dr. Pfaffle will participate on a panel titled, ”Regulatory Challenges: Expanding Endpoints,” along with Arsanis’ Chief Development Officer, David Mantus, and moderated by Chief Executive Officer of Scynexis, Marco Taglietti. The panel is scheduled for 11:30 a.m. – 12:00 p.m. ET on Tuesday, September 19, 2017.

Click here to read the full press release.

Source: www.accesswire.com